• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替代肝纤维化评估与胰岛素抵抗在主要心血管事件发生率上的交互作用

Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events.

作者信息

Martinez-Urbistondo Diego, D'Avola Delia, Navarro-González David, Sanchez-Iñigo Laura, Fernandez-Montero Alejandro, Perez-Diaz-Del-Campo Nuria, Bugianesi Elisabetta, Martinez Jose Alfredo, Pastrana Juan Carlos

机构信息

Internal Medicine Department, Clínica Universidad de Navarra, 28027 Madrid, Spain.

Liver Unit, Clínica Universidad de Navarra, 28027 Madrid, Spain.

出版信息

J Clin Med. 2022 Sep 1;11(17):5190. doi: 10.3390/jcm11175190.

DOI:10.3390/jcm11175190
PMID:36079118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9456724/
Abstract

: The combination of easy-to-obtain validated biomarkers is interesting in the prognostic evaluation of patients at cardiovascular risk in a precision medicine scenario. The evaluation of the effect modification of insulin resistance and liver fibrosis with the Triglyceride-Glucose index (TyG) and Fibrosis-4 index (FIB4) might provide prognostic information in patients at cardiovascular risk. A retrospective cohort study was performed with 2055 patients recruited in the Vascular Metabolic CUN cohort. The studied outcome was the incidence rate of major cardiovascular events (MACE). The Systematic Coronary Risk Evaluation (SCORE), FIB4 and TyG indexes were calculated according to validated formulas. FIB4 and TyG showed a synergistic interaction using validated cut-offs for both indexes in the prediction of MACE (Hazard ratio (HR) 1.05 CI95% 1.01-1.08) which remained after adjustment by age, sex, SCORE subgroup, presence of diabetes, or previous MACE using standardized cut-off (HR 2.29 CI95% 1.33-3.94). Finally, a subgroup with significant TyG and FIB4 showed a higher cardiovascular risk in the study population (adjusted HR 3.34 CI 95% 1.94-5.77). The combined interpretation of TyG and FIB4 indexes might have a potential predictive value of major cardiovascular events.

摘要

在精准医学背景下,易于获得的经过验证的生物标志物组合对于心血管疾病风险患者的预后评估具有重要意义。通过甘油三酯-葡萄糖指数(TyG)和纤维化-4指数(FIB4)评估胰岛素抵抗和肝纤维化的效应修饰,可能为心血管疾病风险患者提供预后信息。我们对血管代谢CUN队列中招募的2055例患者进行了一项回顾性队列研究。研究的结局是主要心血管事件(MACE)的发生率。根据经过验证的公式计算系统性冠状动脉风险评估(SCORE)、FIB4和TyG指数。在预测MACE时,FIB4和TyG在使用两个指数的验证临界值时显示出协同相互作用(风险比(HR)1.05,95%置信区间1.01-1.08),在按年龄、性别、SCORE亚组、糖尿病存在情况或既往MACE使用标准化临界值进行调整后,该相互作用仍然存在(HR 2.29,95%置信区间1.33-3.94)。最后,TyG和FIB4显著的亚组在研究人群中显示出更高的心血管风险(调整后HR 3.34,95%置信区间1.94-5.77)。TyG和FIB4指数的联合解读可能对主要心血管事件具有潜在的预测价值。

相似文献

1
Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events.替代肝纤维化评估与胰岛素抵抗在主要心血管事件发生率上的交互作用
J Clin Med. 2022 Sep 1;11(17):5190. doi: 10.3390/jcm11175190.
2
Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.甘油三酯-葡萄糖指数在预测早发冠心病患者不良心血管事件中的作用:一项回顾性队列研究。
Cardiovasc Diabetol. 2022 Jul 29;21(1):142. doi: 10.1186/s12933-022-01576-8.
3
Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.甘油三酯-葡萄糖指数预测糖尿病合并急性冠脉综合征患者的不良心血管事件。
Cardiovasc Diabetol. 2020 Jun 13;19(1):80. doi: 10.1186/s12933-020-01054-z.
4
Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.三酰甘油-葡萄糖指数对非阻塞性冠状动脉心肌梗死患者长期心血管结局的影响。
Nutr Metab Cardiovasc Dis. 2021 Oct 28;31(11):3184-3192. doi: 10.1016/j.numecd.2021.07.027. Epub 2021 Aug 4.
5
Triglyceride Glucose Index for Predicting Major Adverse Cardiovascular Events in Chinese Patients with Hypertension.甘油三酯葡萄糖指数对中国高血压患者主要不良心血管事件的预测价值
Angiology. 2023 Mar;74(3):259-267. doi: 10.1177/00033197221104559. Epub 2022 May 27.
6
Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes.累积三酰甘油-葡萄糖指数与 2 型糖尿病患者主要不良心血管事件的相关性。
Cardiovasc Diabetol. 2022 Aug 23;21(1):161. doi: 10.1186/s12933-022-01599-1.
7
Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.甘油三酯葡萄糖指数联合斑块特征作为 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后心血管结局的新型生物标志物:一项血管内光学相干断层成像研究。
Cardiovasc Diabetol. 2021 Jun 28;20(1):131. doi: 10.1186/s12933-021-01321-7.
8
Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.甘油三酯-葡萄糖指数对冠心病患者不良心血管事件的预后意义:一项系统评价和荟萃分析
Front Cardiovasc Med. 2021 Dec 2;8:774781. doi: 10.3389/fcvm.2021.774781. eCollection 2021.
9
The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis.三酰甘油-葡萄糖指数与急性冠状动脉综合征患者主要不良心血管事件的关系——剂量反应荟萃分析。
Nutr Metab Cardiovasc Dis. 2021 Oct 28;31(11):3024-3030. doi: 10.1016/j.numecd.2021.08.026. Epub 2021 Aug 12.
10
The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults.甘油三酯-葡萄糖指数作为代谢相关脂肪性肝病(MAFLD)的临床有用标志物:一项针对伊朗成年人的基于人群的研究。
J Diabetes Metab Disord. 2022 Jan 11;21(1):97-107. doi: 10.1007/s40200-021-00941-w. eCollection 2022 Jun.

引用本文的文献

1
Clinically Accessible Liver Fibrosis Association with CT Scan Coronary Artery Disease Beyond Other Validated Risk Predictors: The ICAP Experience.临床可及的肝纤维化与CT扫描显示的冠状动脉疾病的关联:超越其他已验证的风险预测指标——ICAP研究经验
J Clin Med. 2025 Feb 13;14(4):1218. doi: 10.3390/jcm14041218.
2
Health and Liver Diagnostic Markers Influencing Glycemia in Subjects with Prediabetes: Preview Study.影响糖尿病前期患者血糖的健康与肝脏诊断标志物:前瞻性研究
Diagnostics (Basel). 2024 Dec 23;14(24):2895. doi: 10.3390/diagnostics14242895.
3
Bridging Metabolic-Associated Steatotic Liver Disease and Cardiovascular Risk: A Potential Role for Ketogenesis.

本文引用的文献

1
Breakthroughs in therapies for NASH and remaining challenges.NASH 治疗方面的突破和尚存的挑战。
J Hepatol. 2022 Jun;76(6):1263-1278. doi: 10.1016/j.jhep.2022.04.002.
2
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.无既往已知肝脏疾病的患者在接受抗凝治疗静脉血栓栓塞症时的肝脏状态和结局。
Intern Emerg Med. 2022 Apr;17(3):725-734. doi: 10.1007/s11739-021-02858-x. Epub 2021 Oct 9.
3
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
连接代谢相关脂肪性肝病与心血管风险:生酮作用的潜在角色
Biomedicines. 2024 Mar 20;12(3):692. doi: 10.3390/biomedicines12030692.
4
Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks.饮酒对肥胖和脂肪性肝病的影响:对代谢途径和心血管风险的共同影响。
Curr Obes Rep. 2024 Sep;13(3):461-474. doi: 10.1007/s13679-024-00560-5. Epub 2024 Mar 23.
5
Health associations of liver enzymes and inflammatory scores with urinary citrus flavonoid metabolites.肝脏酶和炎症评分与尿中柑橘类黄酮代谢物的健康关联。
Food Funct. 2023 Jan 23;14(2):1011-1023. doi: 10.1039/d2fo02846h.
非酒精性脂肪性肝病与致死和非致死性心血管事件风险:一项更新的系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2021 Nov;6(11):903-913. doi: 10.1016/S2468-1253(21)00308-3. Epub 2021 Sep 21.
4
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.EASL 临床实践指南:非侵入性检测评估肝脏疾病严重程度和预后——2021 更新版。
J Hepatol. 2021 Sep;75(3):659-689. doi: 10.1016/j.jhep.2021.05.025. Epub 2021 Jun 21.
5
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.非酒精性脂肪性肝病患者肝纤维化无创性检查诊断准确性的个体患者数据分析荟萃研究。
Gut. 2022 May;71(5):1006-1019. doi: 10.1136/gutjnl-2021-324243. Epub 2021 May 17.
6
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.2型糖尿病、非酒精性脂肪性肝病与心血管风险之间的关系
Curr Diab Rep. 2021 Mar 19;21(5):15. doi: 10.1007/s11892-021-01383-7.
7
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population.肝纤维化标志物是普通人群心血管发病率和死亡率的独立预测因子。
Dig Liver Dis. 2021 Jan;53(1):79-85. doi: 10.1016/j.dld.2020.10.014. Epub 2020 Nov 2.
8
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease.胰岛素抵抗和糖尿病在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2020 May 29;21(11):3863. doi: 10.3390/ijms21113863.
9
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.纤维化分期与非酒精性脂肪性肝病患者结局的相关性:系统评价和荟萃分析。
Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4.
10
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中胰岛素抵抗和致动脉粥样硬化性血脂异常的发病机制
J Clin Transl Hepatol. 2019 Dec 28;7(4):362-370. doi: 10.14218/JCTH.2019.00028. Epub 2019 Nov 29.